NeuroMetrix Reports 1 Million Hours of Data on Chronic Pain Patients Using Quell Therapy

NeuroMetrix Reports 1 Million Hours of Data on Chronic Pain Patients Using Quell Therapy
NeuroMetrix is marking passage of a major milestone: over 1 million hours of therapy and health data pertaining to its Quell wearable intensive nerve stimulation therapeutic technology has been uploaded to the Quell Health Cloud as of Aug. 1. Quell is engineered to help manage moderate to severe chronic pain, such as low back pain, nerve pain, arthritic pain, and fibromyalgia, and can be purchased without a medical prescription. Quell technology is FDA cleared for 24/7 use, and Quell's lightweight, slim design is discreet enough to wear under clothes and while on-the-go. Quell users can control and customize therapy intensity and timing, and track eight dimensions of sleep and therapy trends, directly from an Apple iOS or Android smartphone or tablet app via Bluetooth wireless technology. The app also records up to two years of therapy and sleep history data at intervals from one day to three months (the latter feature is currently iOS only, but expected for Android later this year), providing feedback about therapy utilization, sleep characteristics and activity levels. Accelerometers in portable devices running the Quell apps assist Quell in automatically adjusting therapy levels to meet the user's current needs. At its default setting, Quell will automatically deliver therapy sessions every other hour, and is used six hours a day, on average. NeuroMetrix says Quell's lithium ion rechargeable battery will typically provide between 30 and 40 hours of therapy between charges. NeuroMetrix, which was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, has also announced that it has entered into a partnership with Advantage Healthcare, a marketing and supply chain company, and will explore retail expansion plans with
Subscribe or to access all post and page content.